LIONSGATE TO RELEASE FOURTH QUARTER AND FULL YEAR EARNINGS FOR FISCAL 2025 AND HOLD ANALYST AND INVESTOR CONFERENCE CALL AFTER MARKET CLOSE ON THURSDAY, MAY 22, 2025

2025-05-09 08:03:01

(MENAFN- PR Newswire)

SANTA MONICA, Calif. and VANCOUVER, BC, May 9, 2025 /PRNewswire/ -- Lionsgate (NYSE: LION ) today announced it will release its fourth quarter and full year financial results for the 2025 fiscal year ended March 31, 2025 after market close on Thursday, May 22.

Lionsgate senior management will hold its analyst and investor conference call to discuss its fiscal 2025 financial results at 5:00 P.M. ET/2:00 P.M. PT on Thursday, May 22. Interested parties may listen to the live webcast by visiting the events page on the Lionsgate Investor relations website or via the following link . A full replay will be available starting Thursday evening, May 22, by clicking the same link.

About Lionsgate
Lionsgate (NYSE: LION ) is one of the world's leading standalone, pure play, publicly traded content companies. It brings together diversified motion picture and television production and distribution businesses, a world-class portfolio of valuable brands and franchises, a talent management and production powerhouse and a more than 20,000-title film and television library, all driven by the studio's bold and entrepreneurial culture.

For investor inquiries, please contact:

Nilay Shah
[email protected]
310-255-3651

For media inquiries, please contact:

Laurel Pecchia
[email protected]
310-255-5114

SOURCE Lionsgate

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE? 440k+
Newsrooms &
Influencers 9k+
Digital Media
Outlets 270k+
Journalists
Opted In GET STARTED

MENAFN09052025003732001241ID1109528540

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.